Jordy G. Van Der Zwet
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways.
Journal: Frontiers in oncology
Published: March 27, 2022
STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL2 and BCLXL following glucocorticoid treatment.
Journal: Haematologica
Published: November 23, 2021
Recurrent NR3C1 Aberrations at First Diagnosis Relate to Steroid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients.
Journal: HemaSphere
Published: July 01, 2020
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.
Journal: Blood cancer discovery
Published: June 04, 2020
Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients.
Journal: Advances in biological regulation
Published: July 25, 2019
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.
Journal: Cancer cell
Published: November 03, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026